InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
0%
T+90 mean return
-18.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by LASEZKAY GEORGE M, Chief Executive Officer. Director active across 1 company, notably Clearside Biomedical, Inc.. Cumulatively, 10 reports have been recorded. Split: 0 buy · 8 sells. Total volume traded: €136k. History available since 21 June 2021. The latest transaction was disclosed on 19 January 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
18,000 shares@ US$1.2715.4% of flowCommon StockSEC:0001209191-24-001960:0
20,030 shares@ US$1.4619.9% of flowCommon StockSEC:0001209191-23-004274:0
97,500 shares0Common StockSEC:0001209191-22-004191:0
97,500 shares0Common StockSEC:0001209191-22-004191
5,100 shares@ US$2.460.015% mcap12.5% of flowCommon StockSEC:0001209191-22-003201:0
5,100 shares@ US$2.468.1% of flowCommon StockSEC:0001209191-22-003201
3,525 shares@ US$6.460.027% mcap22.0% of flowCommon StockSEC:0001209191-21-057459:0
3,525 shares@ US$6.4614.2% of flowCommon StockSEC:0001209191-21-057459
3,707 shares@ US$4.3810.0% of flowCommon StockSEC:0001209191-21-042805
3,707 shares@ US$4.380.019% mcap15.4% of flowCommon StockSEC:0001209191-21-042805:0
10 of 10 declarations
About LASEZKAY GEORGE M
George M. Lasezkay is the CEO of Clearside Biomedical, Inc. He leads the company, overseeing its operations and strategy to ensure growth and success in the market.
